Correlation Between Chorokbaem Healthcare and AptaBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Chorokbaem Healthcare and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chorokbaem Healthcare and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chorokbaem Healthcare Co and AptaBio Therapeutics, you can compare the effects of market volatilities on Chorokbaem Healthcare and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chorokbaem Healthcare with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chorokbaem Healthcare and AptaBio Therapeutics.
Diversification Opportunities for Chorokbaem Healthcare and AptaBio Therapeutics
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Chorokbaem and AptaBio is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Chorokbaem Healthcare Co and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and Chorokbaem Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chorokbaem Healthcare Co are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of Chorokbaem Healthcare i.e., Chorokbaem Healthcare and AptaBio Therapeutics go up and down completely randomly.
Pair Corralation between Chorokbaem Healthcare and AptaBio Therapeutics
Assuming the 90 days trading horizon Chorokbaem Healthcare Co is expected to under-perform the AptaBio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Chorokbaem Healthcare Co is 1.34 times less risky than AptaBio Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The AptaBio Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 1,220,000 in AptaBio Therapeutics on September 2, 2024 and sell it today you would lose (568,000) from holding AptaBio Therapeutics or give up 46.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Chorokbaem Healthcare Co vs. AptaBio Therapeutics
Performance |
| Timeline |
| Chorokbaem Healthcare |
| AptaBio Therapeutics |
Chorokbaem Healthcare and AptaBio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Chorokbaem Healthcare and AptaBio Therapeutics
The main advantage of trading using opposite Chorokbaem Healthcare and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chorokbaem Healthcare position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.| Chorokbaem Healthcare vs. AptaBio Therapeutics | Chorokbaem Healthcare vs. KT Hitel | Chorokbaem Healthcare vs. SillaJen | Chorokbaem Healthcare vs. Cytogen |
| AptaBio Therapeutics vs. ABL Bio | AptaBio Therapeutics vs. Helixmith Co | AptaBio Therapeutics vs. OliX PharmaceuticalsInc | AptaBio Therapeutics vs. Oscotec |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |